{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:06:07Z","timestamp":1791259567836,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Aggregation of \u03b1-synuclein (\u03b1-syn) has been implicated in multiple neurodegenerative disorders including Parkinson\u2019s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), collectively grouped as synucleinopathies. Recently, recombinant antibody fragments (Fab, scFvs and diabodies) against \u03b1-syn have emerged as an alternative to the traditional full-length antibody in immunotherapeutic approaches owing to their advantages including smaller size and higher stability, specificity and affinity. However, most of the recombinant antibody fragments tend to be expressed as inclusion bodies (IBs) making its purification extremely challenging. In the current study, a single-chain variable fragment (scFv-F) antibody, targeting the pathogenic \u03b1-syn fibrils, was engineered and expressed in E. coli. Majority of the expressed scFv-F accumulated in insoluble aggregates as IBs. A variety of mild and harsh solubilizing conditions were tested to solubilize IBs containing scFv-F to obtain the active protein. To preserve secondary structure and bioactivity, a mild solubilizing protocol involving 100 mM Tris, pH 12.5 with 2 M urea was chosen to dissolve IBs. Slow on-column refolding method was employed to subsequently remove urea and obtain active scFv-F. A three-dimensional (3D) model was built using homology modeling and subjected to molecular docking with the known \u03b1-syn structure. Structural alignment was performed to delineate the potential binding pocket. The scFv-F thus purified demonstrated high specificity towards \u03b1-syn fibrils compared to monomers. Molecular modeling studies suggest that scFv-F shares the same structural topology with other known scFvs. We present evidence through structural docking and alignment that scFv-F binds to \u03b1-syn C-terminal region. In conclusion, mild solubilization followed by slow on-column refolding can be utilized as a generalized and efficient method for hard to purify disease relevant insoluble proteins and\/or antibody molecules from IBs.<\/jats:p>","DOI":"10.1371\/journal.pone.0241773","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T18:24:09Z","timestamp":1604687049000},"page":"e0241773","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression, purification and characterization of \u03b1-synuclein fibrillar specific scFv from inclusion bodies"],"prefix":"10.1371","volume":"15","author":[{"given":"Vijay","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indulekha P.","family":"Sudhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5444-3910","authenticated-orcid":true,"given":"Zeyaul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant N.","family":"Vaikath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam","family":"Hmila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Lukacsovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna R.","family":"Kolatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-8084","authenticated-orcid":true,"given":"Omar M. A.","family":"El-Agnaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"pone.0241773.ref001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"MG Spillantini","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 6","key":"pone.0241773.ref002","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"KA Jellinger","year":"2003","journal-title":"Mov Disord"},{"issue":"1","key":"pone.0241773.ref003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40120-018-0122-z","article-title":"Emerging Immunotherapies for Parkinson Disease","volume":"8","author":"SMA Zella","year":"2019","journal-title":"Neurol Ther"},{"key":"pone.0241773.ref004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2017.05.002","article-title":"Differential effects of immunotherapy with antibodies targeting alpha-synuclein oligomers and fibrils in a transgenic model of synucleinopathy","volume":"104","author":"O El-Agnaf","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"9","key":"pone.0241773.ref005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/1871527317666180315161626","article-title":"Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases","volume":"17","author":"KY Chia","year":"2018","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"9","key":"pone.0241773.ref006","doi-asserted-by":"crossref","first-page":"19109","DOI":"10.3390\/ijms140919109","article-title":"Single-chain fragment variable passive immunotherapies for neurodegenerative diseases","volume":"14","author":"L Huang","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0241773.ref007","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2174\/1570159X01666160930121647","article-title":"Recombinant Antibody Fragments for Neurodegenerative Diseases","volume":"15","author":"K Manoutcharian","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"pone.0241773.ref008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12010-012-9962-7","article-title":"Recombinant single-chain antibody with the Trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier","volume":"169","author":"N Skrlj","year":"2013","journal-title":"Appl Biochem Biotechnol"},{"key":"pone.0241773.ref009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2016.03.014","article-title":"Antibody therapies in CNS diseases","volume":"120","author":"PO Freskgard","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"pone.0241773.ref010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/bp0497839","article-title":"Production of nonclassical inclusion bodies from which correctly folded protein can be extracted","volume":"21","author":"S Jevsevar","year":"2005","journal-title":"Biotechnol Prog"},{"key":"pone.0241773.ref011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12934-015-0208-6","article-title":"A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form","volume":"14","author":"X Qi","year":"2015","journal-title":"Microb Cell Fact"},{"key":"pone.0241773.ref012","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4939-2205-5_15","article-title":"Solubilization and refolding of inclusion body proteins","volume":"1258","author":"A Singh","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"4","key":"pone.0241773.ref013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1263\/jbb.99.303","article-title":"Solubilization and refolding of bacterial inclusion body proteins","volume":"99","author":"SM Singh","year":"2005","journal-title":"J Biosci Bioeng"},{"issue":"1","key":"pone.0241773.ref014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pep.2011.09.004","article-title":"Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form","volume":"81","author":"SM Singh","year":"2012","journal-title":"Protein Expr Purif"},{"issue":"4","key":"pone.0241773.ref015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tibtech.2006.02.007","article-title":"Protein quality in bacterial inclusion bodies","volume":"24","author":"S Ventura","year":"2006","journal-title":"Trends Biotechnol"},{"issue":"1","key":"pone.0241773.ref016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2043-7129-1-2","article-title":"Microwave assisted solubilization of inclusion bodies","volume":"1","author":"I Datta","year":"2013","journal-title":"Sustainable Chemical Processes"},{"key":"pone.0241773.ref017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology","volume":"79","author":"NN Vaikath","year":"2015","journal-title":"Neurobiol Dis"},{"key":"pone.0241773.ref018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2014.11.007","article-title":"Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils","volume":"74","author":"MT Ardah","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"1","key":"pone.0241773.ref019","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1038\/s41598-017-09654-8","article-title":"Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology","volume":"7","author":"M Bertoni","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0241773.ref020","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Y Yan","year":"2020","journal-title":"Nat Protoc"},{"issue":"W1","key":"pone.0241773.ref021","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Y Yan","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"pone.0241773.ref022","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"1","key":"pone.0241773.ref023","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pep.2004.05.007","article-title":"On-column refolding of recombinant human interleukin-4 from inclusion bodies","volume":"37","author":"MR Razeghifard","year":"2004","journal-title":"Protein Expr Purif"},{"issue":"1","key":"pone.0241773.ref024","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1038\/s41598-020-65035-8","article-title":"Fibrillar form of alpha-synuclein-specific scFv antibody inhibits alpha-synuclein seeds induced aggregation and toxicity","volume":"10","author":"V Gupta","year":"2020","journal-title":"Sci Rep"},{"issue":"W1","key":"pone.0241773.ref025","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"A Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"pone.0241773.ref026","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy","volume":"28","author":"Y Li","year":"2018","journal-title":"Cell Res"},{"issue":"2","key":"pone.0241773.ref027","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jmb.2010.07.001","article-title":"Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody","volume":"402","author":"EJ De Genst","year":"2010","journal-title":"J Mol Biol"},{"issue":"1","key":"pone.0241773.ref028","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0959-440X(95)80015-S","article-title":"Protein-peptide interactions","volume":"5","author":"RL Stanfield","year":"1995","journal-title":"Curr Opin Struct Biol"},{"issue":"5","key":"pone.0241773.ref029","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jnc.14713","article-title":"Antibodies against alpha-synuclein: tools and therapies","volume":"150","author":"NN Vaikath","year":"2019","journal-title":"J Neurochem"},{"issue":"27","key":"pone.0241773.ref030","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1016\/j.febslet.2006.10.071","article-title":"Effect of temperature on protein quality in bacterial inclusion bodies","volume":"580","author":"NS de Groot","year":"2006","journal-title":"FEBS Lett"},{"key":"pone.0241773.ref031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12934-015-0222-8","article-title":"Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process","volume":"14","author":"A Singh","year":"2015","journal-title":"Microb Cell Fact"},{"issue":"2","key":"pone.0241773.ref032","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0003-2697(03)00384-1","article-title":"Solubilization and refolding of inclusion body proteins in reverse micelles","volume":"320","author":"AA Vinogradov","year":"2003","journal-title":"Anal Biochem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:02:08Z","timestamp":1618279328000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241773"}},"subtitle":[],"editor":[{"given":"Yong-Bin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0241773","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]}}}